ALEXANDRIA, Va., Feb. 25 -- Brigham and Women's Hospital, Boston, Beth Israel Deaconess Medical Center, Boston, and General Hospital, Boston, have been assigned a patent (9,575,072) developed by four co-inventors for "diagnostic and therapeutic uses of gelsolin in renal failure." The co-inventors are Ravi Thadhani, Boston, Thomas P. Stossel, Belmont, Massachusetts, Po-Shun Lee, Brookline, Massachusetts, and Ananth Karumanchi, Chestnut Hill, Massachusetts.

The patent application wa . . .